Mercedes Nadal-Serrano

5PUBLICATIONS
27CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersMetabolic medicineCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 04, 2026
Oleocanthal Induces Mitochondrial Dysfunction in Breast Cancer Cell Lines Depending on c-MET Expression.

|Jan 08, 2025
Obesity-Related Inflammation Reduces Treatment Sensitivity and Promotes Aggressiveness in Luminal Breast Cancer Modulating Oxidative Stress and Mitochondria.

Pere Miquel Morla-Barcelo, Lucas Melguizo-Salom, Pilar Roca

|Sep 28, 2024
Tumorspheres as In Vitro Model for Identifying Predictive Chemoresistance and Tumor Aggressiveness Biomarkers in Breast and Colorectal Cancer.

Toni Martinez-Bernabe, Pere Miquel Morla-Barcelo, Lucas Melguizo-Salom

|May 24, 2024
Metformin: From Diabetes to Cancer-Unveiling Molecular Mechanisms and Therapeutic Strategies.

Emilia Amengual-Cladera, Pere Miquel Morla-Barcelo, Andrea Morán-Costoya

|Oct 12, 2022
Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody-Drug Conjugates in Breast Cancer.

Santiago Duro-Sánchez, Mercedes Nadal-Serrano, Marta Lalinde-Gutiérrez

Pageof 1

Frequent Collaborators

4 joint publications

Pilar Roca

4 joint publications

Jorge Sastre-Serra

4 joint publications

Pere Miquel Morla-Barcelo

2 joint publications

Lucas Melguizo-Salom